Results 221 to 230 of about 63,987 (250)

Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification

Circulation, 2016
Alfredo Criollo, Min Xie, Joseph Hill
exaly  

Chitosan-based nanoparticles as drug delivery systems for doxorubicin: Optimization and modelling

Carbohydrate Polymers, 2016
Silva J C, Borges J P, Paula Soares
exaly  

Doxorubicin see Mitomycin/doxorubicin

Reactions, 1987
openaire   +1 more source

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Annals of Oncology, 2003
Flavia Zanaboni, C Coens, J P Guastalla   +2 more
exaly  

Molecular mechanism of doxorubicin-induced cardiomyopathy – An update

European Journal of Pharmacology, 2018
Abilash Valsala Gopalakrishnan, Kaviyarasi Renu, Sankarganesh Arunachalam   +2 more
exaly  

In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates

Journal of Controlled Release, 2000
T G Park
exaly  

Congestive heart failure in patients treated with doxorubicin

Cancer, 2003
Sandra Swain
exaly  

Doxorubicin see Daunorubicin/doxorubicin

Reactions Weekly, 1990
openaire   +1 more source

Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin

Circulation, 2006
Chi Kong Li, Wood Yee Chan, Tai Fai Fok
exaly  

Doxorubicin see Cisplatin/doxorubicin

Reactions, 1988
openaire   +1 more source